Search

Your search keyword '"Cg Faber"' showing total 234 results

Search Constraints

Start Over You searched for: Author "Cg Faber" Remove constraint Author: "Cg Faber"
234 results on '"Cg Faber"'

Search Results

1. Network topology of NaV1.7 mutations in sodium channel-related painful disorders

2. CI-PERINOMS: chemotherapy-induced peripheral neuropathy outcome measures study

4. The Experience Sampling Method in Small Fiber Neuropathy: The Influence of Psychosocial Factors on Pain Intensity and Physical Activity.

5. Biopsychosocial rehabilitation therapy in small fiber neuropathy: research protocol to study the effect of rehabilitation treatment.

6. The COVID-19 Pandemic and Its Influence on Patients With Myotonic Dystrophy Type 1: Lessons Learned.

7. Genetic associations of neuropathic pain and sensory profile in a deeply phenotyped neuropathy cohort.

8. Comprehensive four-year disease progression assessment of myotonic dystrophy type 1.

9. Population-based incidence rates of 15 neuromuscular disorders: a nationwide capture-recapture study in the Netherlands.

10. Use of the experience sampling method in adolescents with Duchenne muscular dystrophy: a feasibility study.

11. Broadening the Genetic Spectrum of Painful Small-Fiber Neuropathy through Whole-Exome Study in Early-Onset Cases.

12. Patient satisfaction and patient accessibility in a small fiber neuropathy diagnostic service in the Netherlands: A single-center, prospective, survey-based cohort study.

13. Development, validation and feasibility of a Patient Satisfaction Questionnaire for evaluating the quality performance of a diagnostic small fibre neuropathy service: A qualitative study.

14. Peripheral Pain Captured Centrally: Altered Brain Morphology on MRI in Small Fiber Neuropathy Patients With and Without an SCN9A Gene Variant.

15. Small fiber neuropathy.

16. The Role of Cognition, Affective Symptoms, and Apathy in Treatment Adherence with Noninvasive Home Mechanical Ventilation in Myotonic Dystrophy.

17. Cost of illness of patients with small fiber neuropathy in the Netherlands.

18. Archival skin biopsy specimens as a tool for miRNA-based diagnosis: Technical and post-analytical considerations.

19. TRPA1 rare variants in chronic neuropathic and nociplastic pain patients.

20. Role of respiratory characteristics in treatment adherence with noninvasive home mechanical ventilation in myotonic dystrophy type 1, a retrospective study.

21. Acceptability, usability and feasibility of experienced sampling method in chronic secondary pain syndromes.

22. Integrative miRNA-mRNA profiling of human epidermis: unique signature of SCN9A painful neuropathy.

24. IgM anti-MAG ± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M-protein peripheral neuropathies.

25. Genetic Profiling of Sodium Channels in Diabetic Painful and Painless and Idiopathic Painful and Painless Neuropathies.

26. Efficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment randomised withdrawal study.

27. An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1.

28. Myotonic dystrophy type 1: A comparison between the adult- and late-onset subtype.

29. Energy Expenditure, Body Composition, and Skeletal Muscle Oxidative Capacity in Patients with Myotonic Dystrophy Type 1.

31. Recent advances for using human induced-pluripotent stem cells as pain-in-a-dish models of neuropathic pain.

32. Anxiety and depression in small fiber neuropathy.

33. Peripheral Ion Channel Genes Screening in Painful Small Fiber Neuropathy.

34. Living with small fiber neuropathy: insights from qualitative focus group interviews.

35. Pain triangle phenomenon in possible association with SCN9A: A case report.

36. Small fiber neuropathies: expanding their etiologies.

37. Skin biopsy and small fibre neuropathies: facts and thoughts 30 years later.

38. Peripheral Ion Channel Gene Screening in Painful- and Painless-Diabetic Neuropathy.

39. Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.

40. The applicability of the digit wrinkle scan to quantify sympathetic nerve function.

41. Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.

43. Corneal nerve loss is related to the severity of painful diabetic neuropathy.

44. Lacosamide Inhibition of Na V 1.7 Channels Depends on its Interaction With the Voltage Sensor Domain and the Channel Pore.

45. Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands.

47. A novel gain-of-function sodium channel β2 subunit mutation in idiopathic small fiber neuropathy.

48. Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity.

49. Prevalence of Bladder and Bowel Dysfunction in Duchenne Muscular Dystrophy Using the Childhood Bladder and Bowel Dysfunction Questionnaire.

50. The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS).

Catalog

Books, media, physical & digital resources